For Immediate Release:
March 10, 2022
Statement from Health Care for All Executive Director Amy Rosenthal on Connector Seal of Approval Announcement
BOSTON – Health Care for All Executive Director Amy Rosenthal issued the following statement on the Massachusetts Health Connector’s new policy to eliminate co-pay requirements from ConnectorCare plan members for 20 widely used medications, for sick-visits to primary care providers, and for treatment of four chronic conditions: diabetes, asthma, coronary artery disease, and hypertension:
“The initiative announced today by the Connector represents an enormous step forward for the Commonwealth in making care more accessible and equitable. By eliminating co-pays for critical medications and services used to treat chronic conditions that disproportionately impact communities of color and low-income consumers, the Connector is showing that it is possible to do more than just talk about health equity. These actions represent concrete steps to make care more affordable and accessible to the communities that have faced the greatest barriers to accessing it.
“Health Care For All has long advocated for using this type of benefit design to eliminate cost barriers to help patients access the most critical care, and to do so with a focus on advancing health equity. We urge the legislature and other state agencies to consider expanding on this model to benefit Massachusetts residents with other types of health insurance.”